MarketWatch
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.
View original source — MarketWatch ↗
Related stories
CNBC
BusinessAug 19, 2026 · 1 min
U.S. government debt passes $40 trillion mark for the first time
CNBC
CNBC
BusinessAug 19, 2026 · 1 min
Trump bemoans Fed interest rate policy, says U.S. should be paying much less
CNBC
The New York Times
BusinessAug 19, 2026 · 1 min
Chinese Start-Up Lands Reusable Rocket for the First Time
The New York Times
Bloomberg
BusinessAug 19, 2026 · 1 min
Moderna Surges as Stocks Rise & Long-Term Yields Retreat | Closing Bell
Bloomberg